Promising hematologists begin year-long program to pursue careers in clinical research

July 13, 2009

(WASHINGTON, July 13, 2009) - Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology (ASH) Clinical Research Training Institute.

The ASH Clinical Research Training Institute provides aspiring hematologists with the necessary tools to begin careers in clinical research. The annual program begins with a week-long summer workshop that focuses on the fundamentals of research and includes practical information on topics such as how to form and sustain a multi-disciplinary research team, how to secure research funding, and how to navigate the regulatory rules governing clinical trials.

In addition to attending lectures and small-group discussions, participants work on their own proposed clinical research projects with input from expert faculty. Further mentoring opportunities are provided at two subsequent sessions, one at the ASH annual meeting in December and one the following spring.

"It is crucial to provide fellows and junior faculty with the chance to develop their clinical research skills," said ASH President Nancy Berliner, MD, Chief of Hematology at Brigham and Women's Hospital in Boston, and Professor of Medicine at Harvard Medical School. "But even more importantly, this program provides each participant with a supportive peer network and introduces them to leaders in hematology who will serve as mentors throughout their careers."

The 2009 ASH Clinical Research Training Institute participants are:This program is offered to hematology and hematology/oncology fellows, as well as junior faculty who are within three years of completing their fellowship training at academic medical centers in the United States and Canada.
-end-
To arrange an interview with a Clinical Research Training Institute participant, please contact Patrick C. Irelan, ASH Communications Assistant, at 202-776-0544 or pirelan@hematology.org.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September, ASH launched Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options.

American Society of Hematology

Related Clinical Research Articles from Brightsurf:

Day after COVID-19: Time to rethink oncology clinical research
This Viewpoint discusses how the COVID-19 pandemic may reshape clinical practice and clinical research as new technologies are incorporated and old practices are revisited and revamped.

Pregnant and lactating women with COVID-19: Scant clinical research
Pregnant and breastfeeding women have been excluded from clinical trials of drugs to treat COVID-19, and as result, there is no safety data to inform clinical decisions.

Serum irisin: Pathogenesis and clinical research in cardiovascular diseases
In a new publication from Cardiovascular Innovations and Applications; Lutfu Askin, Kader Eliz Uzel, Okan Tanriverdi and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider serum irisin pathogenesis and clinical research in cardiovascular diseases.

People fearful of taking part in vital clinical research
A review, led by researchers at the University of York and Hull York Medical School, has found that fear about testing new treatments and possible side effects was the most common reason given by patients for not wanting to participate.

Clinical research improves health of UK economy and NHS
The value of clinical research to the NHS, the UK economy and jobs market has been evaluated in a new report, which provides an assessment of the economic impact of the National Institute for Health Research Clinical Research Network's (NIHR CRN) activities to support clinical research in England.

Research discovery leads to new clinical trial for myelofibrosis patients
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

New research: Financial disclosure lacking in publication of clinical trials
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows.

How to ethically conduct clinical research during public health emergencies
Carnegie Mellon University's Alex John London, a prominent bioethicist, has co-authored a viewpoint article in PLOS: Neglected Tropical Diseases on the ethics of clinical research during public health emergencies, like Ebola outbreaks.

Early results from clinical trials not all they're cracked up to be, shows new research
When people are suffering from a chronic medical condition, they may place their hope on treatments in clinical trials that show early positive results.

Collection provides tools to improve clinical research in Africa and Asia
Quality assurance of clinical research is critical to ensure meaningful results in compliance with universal ethical standards.

Read More: Clinical Research News and Clinical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.